Results 171 to 180 of about 413,028 (398)
Similarities and Differences in the Development of Laboratory Strains and Freshly Isolated Strains of Herpes Simplex Virus in HEp-2 Cells: Electron Microscopy [PDF]
, 1969 Jerome Schwartz, Bernard Roizman
openalex +1 more source
The Journal of Dermatology, EarlyView.ABSTRACT Clinical trials have demonstrated the efficacy and safety of guselkumab in patients with moderate‐to‐severe plaque psoriasis. Real‐world evidence for guselkumab in Korea is needed to establish drug safety and effectiveness under real‐world practice in this population.
Bong Seok Shin +13 more
wiley +1 more source
VARIANTS OF HERPES SIMPLEX VIRUS: ISOLATION, CHARACTERIZATION, AND FACTORS INFLUENCING PLAQUE FORMATION [PDF]
, 1963 Fred Rapp
openalex +1 more source
Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management
Neurotherapeutics, 2016 M. Bradshaw, A. Venkatesan
semanticscholar +1 more source
Aging Cell, EarlyView.Senolytic therapy restores neurovascular function, blood–brain barrier integrity, and cognitive performance in aged mice by targeting endothelial senescence. Findings highlight that brain microvascular endothelial cells are highly vulnerable to aging‐induced senescence, and early intervention in middle age may be the most effective strategy to prevent ...
Boglarka Csik +20 more
wiley +1 more source
Electron Microscopy of Herpes Simplex Virus IV. Studies with Ferritin-conjugated Antibodies [PDF]
, 1968 S. Nii +3 more
openalex +1 more source
Clinical periodontal diagnosis
Periodontology 2000, EarlyView., 2023 Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi +5 more
wiley +1 more source
A Possible Role of γA-Immunoglobulin in Herpes Simplex Virus Infection in Man [PDF]
, 1966 T. Tokumaru
openalex +1 more source
Allergy, EarlyView.Data were included from adolescents with moderate‐to‐severe AD treated with the JAK1 inhibitor abrocitinib (200 mg/100 mg) across JADE clinical trials. Improvements in skin clearance (per EASI‐75) and itch (per PP‐NRS4) were maintained for up to 112 weeks with both abrocitinib doses.
Amy S. Paller +13 more
wiley +1 more source